Project Grant HT94252410239
Award Date
5/1/24
Completion Date
4/30/26
Dollars Obligated
$346K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02215, USA
Similar Awards
The Defense Health Agency awarded Brigham & Women's Hospital Inc. a $253,636 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2025 to investigate the role of the secreted factor CTHRC1 in the pathogenesis of tuberous sclerosis complex. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care...
This federal Project Grant award for $428,220, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports innovative research to unravel the role of localized small extracellular vesicles in the progression of pulmonary hypertension. The research, conducted by the University of Colorado-Denver, aims to provide novel insights into this condition that is of particular relevance to military personnel and veterans. The project will run...
This $409,792 Project Grant award was made by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award supports research to develop a "Highly Penetrating Nanodisc for Targeting Fibroblast Plasticity in Pulmonary Fibrosis". The primary awardee is Brigham & Women's Hospital Inc., a renowned academic medical center in Boston, Massachusetts. The project involves collaboration with researchers at Massachusetts General...
This federal Project Grant award of $1,991,326.00, awarded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research at Beth Israel Deaconess Medical Center, Inc. (Bidmc) aimed at suppressing barrier antimicrobial defenses in the context of trauma. The 3-year grant, with a performance period from September 30, 2024 to September 29, 2027, will enable Bidmc, a prominent academic medical center in...
The federal Project Grant award of $1,715,075.00 was provided by the Defense Health Agency to Beth Israel Deaconess Medical Center, Inc. (Bidmc) under the Military Medical Research and Development (CFDA 12.420) program. The funding supports research on "The Role of TBI Derived DAMPS in Bacterial Pneumonia" over a period from September 30, 2023 to September 29, 2026. As a major academic medical center and teaching hospital, Bidmc has an extensive portfolio of federal grants and...
This $334,000 Project Grant award from the Department of Defense (DOD) Defense Health Agency supports research by The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to analyze extracellular vesicles in exhaled breath condensates for the diagnosis and monitoring of pulmonary fibrosis. The research project, funded under the DOD's Military Medical Research and Development program (CFDA 12.420), aims to develop improved diagnostic and monitoring capabilities...
The Department of Defense's Defense Health Agency has awarded a $866,250 Project Grant to the Trustees of Boston University, doing business as the Boston University Medical Campus, under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2024, will fund a research project titled "TARGETING TRANSCRIPTIONAL NETWORKS DIRECTING IMMUNE EVASION IN PROGRESSIVE BRONCHIAL PREMALIGNANT LESIONS" through June 30, 2027. As a leading private research...
The Defense Health Agency awarded a $1.64 million Project Grant to the Massachusetts General Hospital for research titled "Defining Novel Cellular Circuitry and Communication in Fibrous Dysplasia." The grant period runs from August 1, 2023 through July 31, 2027 under the Military Medical Research and Development program (CFDA 12.420). This funding will support MGH's efforts to investigate medical solutions for battlefield injuries and transform military and public health through...
The Defense Health Agency awarded a $772,626 Project Grant to Brigham & Women's Hospital Inc. under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, effective from August 1, 2025 to July 31, 2028, will fund preclinical validation of gene therapy in mouse models of tuberous sclerosis complex (TSC) and lymphangioleiomyomatosis (LAM). Brigham & Women's Hospital Inc., a prominent academic medical center and research institution in Boston,...
The Department of the Army Medical Command awarded a $1,559,896 Project Grant to Massachusetts General Hospital through the Military Medical Research and Development program. The grant will fund research from September 2022 through August 2026 to define small airways disease as a therapeutic target in post-acute sequelae of COVID-19. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of improving military and public...